Considering that BMPR2, BMPR1A, and ACVR1 are all receptors for bone morphogenetic proteins (BMPs), we have selected the receptor that exhibits the most differential response between KMT2A-r and KMT2A-w ALL cells for further validation, i.e., BMPR2. Here, ACVR1 is linked to acute lymphoblastic leukemia.